Mitos Pharmaceuticals: Clinical Trials

2 trials sponsored by Mitos Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Unknown 1

Follow Mitos Pharmaceuticals: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy Study of Tempol to Prevent Hair Loss From Radiotherapy to the Brain
7% (w/v) Tempol alcohol-based gel (MTS-01), alcohol-based gel - Alopecia
Phase 2UnknownMitos Pharmaceuticals162008-11-012008-12-03
Safety and Preliminary Efficacy Study of MTS-01 for the Prevention of Alopecia Induced by WHole Brain Radiotherapy
MTS-01, Placebo - Alopecia
Phase 2TerminatedMitos Pharmaceuticals162007-04-012008-07-11

Conditions studied

Alopecia (2)

Interventions

Ethanol (1)  ·  tempol (1)

Countries

United States (1)

Top investigators

James Metz, MD (1)